| Application no. and date | 08757278.0 (espacenet) (Federated) (European Patent Register), 20080625 | | Patent/reg. no. and date | DK/EP 2158315, 20160323 | | Publication date | 20100303 | | Priority no. and date | US 937112 P, 20070625, US 69056, 20080312 | | EP pub. no. and date |
EP 2158315 20100303 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | P81601720DK00E | | Inventor | URECH, David, Schreinerweg 5
8708 Männedorf, CH,
BORRAS, Leonardo, Bundentalstrasse 1
8952 Schlieren, CH | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , C07K 16/00 (2006.01) , C12N 15/09 (2006.01) , C12N 15/13 (2006.01) | | Title | FREMGANGSMÅDER TIL MODIFICERING AF ANTISTOFFER OG MODIFICEREDE ANTISTOFFER MED FORBEDREDE FUNKTIONELLE EGENSKABER | | Int. application no. | CH2008000285 | | Int. publication no. | WO2009000099 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
